HWAM
SUPN icon

Hennion & Walsh Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Hennion & Walsh Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.2M Buy
90,213
+1,759
+2% +$84.5K 0.12% 222
2026
Q1 		$4.57M Buy
88,454
+7,803
+10% +$397K 0.15% 167
2025
Q4 		$4.01M Sell
80,651
-21,089
-21% -$1.03M 0.14% 186
2025
Q3 		$4.86M Buy
101,740
+6,899
+7% +$278K 0.18% 139
2025
Q2 		$2.99M Buy
94,841
+17,231
+22% +$552K 0.12% 222
2025
Q1 		$2.54M Buy
77,610
+11,304
+17% +$401K 0.11% 226
2024
Q4 		$2.4M Buy
66,306
+25,004
+61% +$880K 0.11% 245
2024
Q3 		$1.29M Sell
41,302
-1,147
-3% -$35.8K 0.06% 395
2024
Q2 		$1.14M Buy
42,449
+2,605
+7% +$75.5K 0.06% 392
2024
Q1 		$1.36M Buy
39,844
+16,605
+71% +$494K 0.07% 343
2023
Q4 		$673K Buy
+23,239
New +$616K 0.04% 496
2022
Q4 		– Sell
-121,835
Closed -$4.12M – 806
2022
Q3 		$4.12M Sell
121,835
-6,883
-5% -$224K 0.27% 89
2022
Q2 		$3.72M Sell
128,718
-73,964
-36% -$2.12M 0.23% 117
2022
Q1 		$6.55M Sell
202,682
-14,360
-7% -$440K 0.35% 71
2021
Q4 		$6.33M Sell
217,042
-27,980
-11% -$849K 0.31% 88
2021
Q3 		$6.54M Sell
245,022
-7,946
-3% -$213K 0.34% 67
2021
Q2 		$7.79M Buy
252,968
+1,364
+0.5% +$41.8K 0.42% 49
2021
Q1 		$6.59M Buy
+251,604
New +$7.04M 0.4% 56

Other funds holding SUPN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
CNAM
Campbell Newman Asset Management Milwaukee, Wisconsin $1.35B AUM 38.87% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
JIR
James Investment Research Alpha, Ohio $984M AUM 36.03% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Hennion & Walsh Asset Management's SUPN Position: Q2 2026 in Review

Hennion & Walsh Asset Management increased its Supernus Pharmaceuticals (SUPN) stake by 2% in Q2 2026, buying an estimated $84.5K and bringing the position to 90,213 shares worth $4.2M. The position accounts for 0.12% of the portfolio, ranked #222.

Hennion & Walsh Asset Management first reported a position in SUPN in Q1 2021 and has held it in 18 quarters since. The position peaked at $7.79M in Q2 2021. 58 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Hennion & Walsh Asset Management held 90,213 shares of Supernus Pharmaceuticals worth $4.2M as of Q2 2026.
  • Hennion & Walsh Asset Management bought 1,759 Supernus Pharmaceuticals shares in Q2 2026, an estimated $84.5K.
  • Supernus Pharmaceuticals made up 0.12% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #222 holding.
  • Hennion & Walsh Asset Management first reported a position in Supernus Pharmaceuticals in Q1 2021 and has held it in 18 quarters since.
  • Hennion & Walsh Asset Management's Supernus Pharmaceuticals position peaked at $7.79M in Q2 2021.
  • 58 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.